BB Biotech AG is a Swiss investment company primarily focused on the biotechnology sector. Its core purpose is to manage equity portfolios of public and private biotech companies, mainly based in the ... BB Biotech AG is a Swiss investment company primarily focused on the biotechnology sector. Its core purpose is to manage equity portfolios of public and private biotech companies, mainly based in the United States and Europe. BB Biotech AG seeks to identify innovative firms engaged in developing and marketing breakthrough medical therapies and technologies, targeting areas such as oncology, neurology, and infectious diseases.
Notably, the company holds stakes in a broad range of biotechnology enterprises, supporting their growth and leveraging advancements in healthcare and life sciences. This strategic involvement allows BB Biotech AG to maintain a diversified portfolio that captures the dynamic nature of the biotech industry.
In the financial markets, BB Biotech AG plays a critical role as a link between biotech innovation and investors seeking exposure to this high-impact sector. Its shares are publicly traded, enabling investors to indirectly participate in the growth of the biotechnology industry while benefiting from the expertise of its management team. BB Biotech AG's insightful investment approach is pivotal in identifying trends and advancements that could shape the future of healthcare.
Pending data availability
Climate Targets Data missing for BB Biotech
We haven’t collected Climate Targets data for BB Biotech yet, or the company
hasn’t made it publicly available.